THE IMPAIRMENT OF ANTITUMOR CYTOTOXIC ACTIVITY OF DENDRITIC CELLS IN PATIENTS WITH MALIGNANT LYMPHOMA DUE TO THE ALTERED EXPRESSION OF TUMOR NECROSIS FACTOR ALPHA

Recent research revealed dendritic cells (DCs) to have direct antitumor cytotoxic activity and to inhibit the growth and proliferation of tumor cells in vitro. The aim of the present study was to investigate the association between the cytotoxic activity of dendritic cells generated in the presence...

Full description

Bibliographic Details
Main Authors: T. V. Tyrinova, O. Yu. Leplina, M. A. Tikhonova, D. S. Batorova, G. Yu. Ushakova, V. V. Sergeevicheva, S. A. Sizikova, I. V. Kryuchkova, A. A. Ostanin, E. R. Chernykh
Format: Article
Language:Russian
Published: Russian Academy of Sciences, Tomsk National Research Medical Center 2016-02-01
Series:Сибирский онкологический журнал
Subjects:
Online Access:https://www.siboncoj.ru/jour/article/view/152
_version_ 1797875966976983040
author T. V. Tyrinova
O. Yu. Leplina
M. A. Tikhonova
D. S. Batorova
G. Yu. Ushakova
V. V. Sergeevicheva
S. A. Sizikova
I. V. Kryuchkova
A. A. Ostanin
E. R. Chernykh
author_facet T. V. Tyrinova
O. Yu. Leplina
M. A. Tikhonova
D. S. Batorova
G. Yu. Ushakova
V. V. Sergeevicheva
S. A. Sizikova
I. V. Kryuchkova
A. A. Ostanin
E. R. Chernykh
author_sort T. V. Tyrinova
collection DOAJ
description Recent research revealed dendritic cells (DCs) to have direct antitumor cytotoxic activity and to inhibit the growth and proliferation of tumor cells in vitro. The aim of the present study was to investigate the association between the cytotoxic activity of dendritic cells generated in the presence of interferon alpha (IFN-DCs) and TNFα expression by IFN-DCs in patients with malignant lymphomas. It was shown that IFN-DCs of malignant lymphoma patients possessed low cytotoxic activity against tumor cell line HEp-2 associated with low expression of transmembrane TNFα (tmTNFα) and high level of soluble TNFα (sTNFα) secretion. Reduced DC cytotoxic activity and low tmTNFα expression on DC surface were observed mainly in Hodgkin’s lymphoma patients. In contrast, IFN-DCs of patients with non-Hodgkin lymphoma were endowed with the ability to lysis of HEp-2 cells and tmTNFα molecule expression was similar to that in IFN-DCs from healthy donors. It was determined that the increase of expression of tmTNFα molecule on lymphoma patient IFN-DCs induced by the addition of TNFα-converting enzyme inhibitor into IFN-DC cultures was associated with the enhancement of IFN-DC cytotoxic activity against HEp-2 cells.
first_indexed 2024-04-10T01:54:50Z
format Article
id doaj.art-e39420cb8732403e85caf8d8aea200d0
institution Directory Open Access Journal
issn 1814-4861
2312-3168
language Russian
last_indexed 2024-04-10T01:54:50Z
publishDate 2016-02-01
publisher Russian Academy of Sciences, Tomsk National Research Medical Center
record_format Article
series Сибирский онкологический журнал
spelling doaj.art-e39420cb8732403e85caf8d8aea200d02023-03-13T09:05:47ZrusRussian Academy of Sciences, Tomsk National Research Medical CenterСибирский онкологический журнал1814-48612312-31682016-02-01155158152THE IMPAIRMENT OF ANTITUMOR CYTOTOXIC ACTIVITY OF DENDRITIC CELLS IN PATIENTS WITH MALIGNANT LYMPHOMA DUE TO THE ALTERED EXPRESSION OF TUMOR NECROSIS FACTOR ALPHAT. V. Tyrinova0O. Yu. Leplina1M. A. Tikhonova2D. S. Batorova3G. Yu. Ushakova4V. V. Sergeevicheva5S. A. Sizikova6I. V. Kryuchkova7A. A. Ostanin8E. R. Chernykh9НИИ фундаментальной и клинической иммунологии, НовосибирскНИИ фундаментальной и клинической иммунологии, НовосибирскНИИ фундаментальной и клинической иммунологии, НовосибирскНИИ фундаментальной и клинической иммунологии, НовосибирскНИИ фундаментальной и клинической иммунологии, НовосибирскНИИ фундаментальной и клинической иммунологии, НовосибирскНИИ фундаментальной и клинической иммунологии, НовосибирскНИИ фундаментальной и клинической иммунологии, НовосибирскНИИ фундаментальной и клинической иммунологии, НовосибирскНИИ фундаментальной и клинической иммунологии, НовосибирскRecent research revealed dendritic cells (DCs) to have direct antitumor cytotoxic activity and to inhibit the growth and proliferation of tumor cells in vitro. The aim of the present study was to investigate the association between the cytotoxic activity of dendritic cells generated in the presence of interferon alpha (IFN-DCs) and TNFα expression by IFN-DCs in patients with malignant lymphomas. It was shown that IFN-DCs of malignant lymphoma patients possessed low cytotoxic activity against tumor cell line HEp-2 associated with low expression of transmembrane TNFα (tmTNFα) and high level of soluble TNFα (sTNFα) secretion. Reduced DC cytotoxic activity and low tmTNFα expression on DC surface were observed mainly in Hodgkin’s lymphoma patients. In contrast, IFN-DCs of patients with non-Hodgkin lymphoma were endowed with the ability to lysis of HEp-2 cells and tmTNFα molecule expression was similar to that in IFN-DCs from healthy donors. It was determined that the increase of expression of tmTNFα molecule on lymphoma patient IFN-DCs induced by the addition of TNFα-converting enzyme inhibitor into IFN-DC cultures was associated with the enhancement of IFN-DC cytotoxic activity against HEp-2 cells.https://www.siboncoj.ru/jour/article/view/152дендритные клетки, интерферон альфа,злокачественные лимфомы, фактор некроза опухоли альфа
spellingShingle T. V. Tyrinova
O. Yu. Leplina
M. A. Tikhonova
D. S. Batorova
G. Yu. Ushakova
V. V. Sergeevicheva
S. A. Sizikova
I. V. Kryuchkova
A. A. Ostanin
E. R. Chernykh
THE IMPAIRMENT OF ANTITUMOR CYTOTOXIC ACTIVITY OF DENDRITIC CELLS IN PATIENTS WITH MALIGNANT LYMPHOMA DUE TO THE ALTERED EXPRESSION OF TUMOR NECROSIS FACTOR ALPHA
Сибирский онкологический журнал
дендритные клетки, интерферон альфа,злокачественные лимфомы, фактор некроза опухоли альфа
title THE IMPAIRMENT OF ANTITUMOR CYTOTOXIC ACTIVITY OF DENDRITIC CELLS IN PATIENTS WITH MALIGNANT LYMPHOMA DUE TO THE ALTERED EXPRESSION OF TUMOR NECROSIS FACTOR ALPHA
title_full THE IMPAIRMENT OF ANTITUMOR CYTOTOXIC ACTIVITY OF DENDRITIC CELLS IN PATIENTS WITH MALIGNANT LYMPHOMA DUE TO THE ALTERED EXPRESSION OF TUMOR NECROSIS FACTOR ALPHA
title_fullStr THE IMPAIRMENT OF ANTITUMOR CYTOTOXIC ACTIVITY OF DENDRITIC CELLS IN PATIENTS WITH MALIGNANT LYMPHOMA DUE TO THE ALTERED EXPRESSION OF TUMOR NECROSIS FACTOR ALPHA
title_full_unstemmed THE IMPAIRMENT OF ANTITUMOR CYTOTOXIC ACTIVITY OF DENDRITIC CELLS IN PATIENTS WITH MALIGNANT LYMPHOMA DUE TO THE ALTERED EXPRESSION OF TUMOR NECROSIS FACTOR ALPHA
title_short THE IMPAIRMENT OF ANTITUMOR CYTOTOXIC ACTIVITY OF DENDRITIC CELLS IN PATIENTS WITH MALIGNANT LYMPHOMA DUE TO THE ALTERED EXPRESSION OF TUMOR NECROSIS FACTOR ALPHA
title_sort impairment of antitumor cytotoxic activity of dendritic cells in patients with malignant lymphoma due to the altered expression of tumor necrosis factor alpha
topic дендритные клетки, интерферон альфа,злокачественные лимфомы, фактор некроза опухоли альфа
url https://www.siboncoj.ru/jour/article/view/152
work_keys_str_mv AT tvtyrinova theimpairmentofantitumorcytotoxicactivityofdendriticcellsinpatientswithmalignantlymphomaduetothealteredexpressionoftumornecrosisfactoralpha
AT oyuleplina theimpairmentofantitumorcytotoxicactivityofdendriticcellsinpatientswithmalignantlymphomaduetothealteredexpressionoftumornecrosisfactoralpha
AT matikhonova theimpairmentofantitumorcytotoxicactivityofdendriticcellsinpatientswithmalignantlymphomaduetothealteredexpressionoftumornecrosisfactoralpha
AT dsbatorova theimpairmentofantitumorcytotoxicactivityofdendriticcellsinpatientswithmalignantlymphomaduetothealteredexpressionoftumornecrosisfactoralpha
AT gyuushakova theimpairmentofantitumorcytotoxicactivityofdendriticcellsinpatientswithmalignantlymphomaduetothealteredexpressionoftumornecrosisfactoralpha
AT vvsergeevicheva theimpairmentofantitumorcytotoxicactivityofdendriticcellsinpatientswithmalignantlymphomaduetothealteredexpressionoftumornecrosisfactoralpha
AT sasizikova theimpairmentofantitumorcytotoxicactivityofdendriticcellsinpatientswithmalignantlymphomaduetothealteredexpressionoftumornecrosisfactoralpha
AT ivkryuchkova theimpairmentofantitumorcytotoxicactivityofdendriticcellsinpatientswithmalignantlymphomaduetothealteredexpressionoftumornecrosisfactoralpha
AT aaostanin theimpairmentofantitumorcytotoxicactivityofdendriticcellsinpatientswithmalignantlymphomaduetothealteredexpressionoftumornecrosisfactoralpha
AT erchernykh theimpairmentofantitumorcytotoxicactivityofdendriticcellsinpatientswithmalignantlymphomaduetothealteredexpressionoftumornecrosisfactoralpha
AT tvtyrinova impairmentofantitumorcytotoxicactivityofdendriticcellsinpatientswithmalignantlymphomaduetothealteredexpressionoftumornecrosisfactoralpha
AT oyuleplina impairmentofantitumorcytotoxicactivityofdendriticcellsinpatientswithmalignantlymphomaduetothealteredexpressionoftumornecrosisfactoralpha
AT matikhonova impairmentofantitumorcytotoxicactivityofdendriticcellsinpatientswithmalignantlymphomaduetothealteredexpressionoftumornecrosisfactoralpha
AT dsbatorova impairmentofantitumorcytotoxicactivityofdendriticcellsinpatientswithmalignantlymphomaduetothealteredexpressionoftumornecrosisfactoralpha
AT gyuushakova impairmentofantitumorcytotoxicactivityofdendriticcellsinpatientswithmalignantlymphomaduetothealteredexpressionoftumornecrosisfactoralpha
AT vvsergeevicheva impairmentofantitumorcytotoxicactivityofdendriticcellsinpatientswithmalignantlymphomaduetothealteredexpressionoftumornecrosisfactoralpha
AT sasizikova impairmentofantitumorcytotoxicactivityofdendriticcellsinpatientswithmalignantlymphomaduetothealteredexpressionoftumornecrosisfactoralpha
AT ivkryuchkova impairmentofantitumorcytotoxicactivityofdendriticcellsinpatientswithmalignantlymphomaduetothealteredexpressionoftumornecrosisfactoralpha
AT aaostanin impairmentofantitumorcytotoxicactivityofdendriticcellsinpatientswithmalignantlymphomaduetothealteredexpressionoftumornecrosisfactoralpha
AT erchernykh impairmentofantitumorcytotoxicactivityofdendriticcellsinpatientswithmalignantlymphomaduetothealteredexpressionoftumornecrosisfactoralpha